< Back to search
Filter
1
Active & Responsive

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

for
Pulmonary Hypertension, Interstitial Lung Disease (ILD),
Location: Boston MA, Providence RI, Charleston SC, Greensboro NC,
Sponsor: Pulmovant, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07333183

Phase2, Recruiting
Active & Responsive

Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis

for
Idiopathic Pulmonary Fibrosis
Location: Quebec, Trois-Rivieres, Montreal, Ajax, Toronto,
Sponsor: Contineum Therapeutics

Sex: All

Age: 40+

Code: NCT07284459

Phase2, Recruiting
Active & Responsive

Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)

for
Idiopathic Pulmonary Fibrosis (IPF)
Location: North Dartmouth MA, DuBois PA, Rock Hill SC,
Sponsor: PureTech

Sex: All

Age: 40+

Code: NCT07284602

Phase3, Recruiting
Active & Responsive

MoblO2 to Maintain Oxygenation

for
COPD (Chronic Obstructive Pulmonary Disease),
Location: Denver CO
Sponsor: Minnesota HealthSolutions

Sex: All

Age: 25 - 70+

Code: NCT07704567

Recruiting
Active & Responsive

MedlyPeds Feasibility Study

for
Pediatric Heart Failure, Congenital Heart Disease (CHD),
Location: Toronto
Sponsor: The Hospital for Sick Children

Sex: All

Age: 8 - 18

Code: NCT07556185

Recruiting

Interested in new lung cancer trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Nucleoside Therapy in Patients With Telomere Biology Disorders

for
Telomere Biology Disorders, Dyskeratosis Congenita,
Location: Boston MA
Sponsor: Suneet Agarwal

Sex: All

Age: 1 - 70

Code: NCT06817590

Phase1, Recruiting
Active & Responsive

Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG

for
Hypertension, Pulmonary,
Location: Norfolk VA, Springfield IL, O'Fallon IL
Sponsor: Eko Devices, Inc.

Sex: All

Age: 18+

Code: NCT07087613

Recruiting
Active & Responsive

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

for
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
Location: New Haven CT, New York NY, Philadelphia PA,
Sponsor: Duke University

Sex: All

Age: 21+

Code: NCT01915511

Recruiting
Active & Responsive

PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

for
Progressive Pulmonary Fibrosis, Interstitial Lung Disease
Location: Worcester MA, Charlottesville VA, Ann Arbor MI,
Sponsor: University of Massachusetts, Worcester

Sex: All

Age: 18 - 70+

Code: NCT06855329

Recruiting
Active & Responsive

The Utility of FDG-PET for Radiation Treatment in NSCLC

for
Lung Neoplasms, Positron Emission Tomography
Location: Calgary
Sponsor: AHS Cancer Control Alberta

Sex: All

Age: 18+

Code: NCT00385164

Recruiting
Active & Responsive

Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking

for
Lung Carcinoma, Tobacco-Related Carcinoma
Location: Philadelphia PA
Sponsor: Ronald Myers

Sex: All

Age: 50 - 70+

Code: NCT05679349

Recruiting
Active & Responsive

Response of Bony Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers With Actionable Driver Mutations.

for
Carcinoma, Non-Small-Cell Lung
Location: Aurora CO, Lone Tree CO
Sponsor: University of Colorado, Denver

Sex: All

Age: 18 - 70+

Code: NCT03958565

Recruiting
Active & Responsive

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

for
Carcinoma, Non-Small-Cell Lung
Location: Halifax, Boston MA, Norwich CT, New Haven CT, Quebec,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06623422

Phase3, Recruiting
Active & Responsive

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

for
Lung Non-Small Cell Carcinoma
Location: Bath ME, Brunswick ME, Portland ME, Scarborough ME,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT07293247

Phase2, Recruiting
Active & Responsive

A Study of DM005 in Patients With Advanced Solid Tumors

for
Carcinoma, Non-Small-Cell Lung,
Location: Fairfax VA, Detroit MI, Dallas TX
Sponsor: Doma Biopharmaceutical（Suzhou）Co., Ltd.

Sex: All

Age: 18+

Code: NCT06515990

Phase1, Phase2, Recruiting
Active & Responsive

Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM

for
Breast Neoplasms, Lung Neoplasms
Location: Providence RI
Sponsor: Brown University

Sex: All

Age: 18+

Code: NCT06974604

Phase2, Recruiting
Active & Responsive

Using Microbiome to Predict Durvalumab Toxicity in Post- Concurrent Chemoradiation Therapy (CCRT) NSCLC Patients

for
NSCLC, Stage III, Locally Advanced Lung Carcinoma
Location: Kansas City KS
Sponsor: Jun Zhang, MD, PhD

Sex: All

Age: 18+

Code: NCT04680377

Recruiting
Active & Responsive

Durvalumab and Tremelimumab in Combination With Chemotherapy in HIV-infected Patients With Non-small Cell Lung Cancer

for
Carcinoma, Non-Small Cell Lung
Location: Baltimore MD, Washington D.C. DC
Sponsor: Georgetown University

Sex: All

Age: 18+

Code: NCT04499053

Phase2, Recruiting
Active & Responsive

BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)

for
Bronchiolitis Obliterans Syndrome, Bronchiolitis Obliterans,
Location: Boston MA, Ann Arbor MI, Seattle WA, Stanford CA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT05922761

Phase2, Recruiting
Active & Responsive

KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)

for
Carcinoma, Non-Small-Cell Lung
Location: Lebanon NH, Philadelphia PA, Columbus OH, Houston TX,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT04165798

Recruiting